Who has invested in InxMed?

China Growth Capital, SDIC, CD Capital are named among the investors backing InxMed.

InxMed Funding: $84M Raised, Series B (2022)

InxMed funding overview

InxMed is based in Nanjing, China. InxMed has raised $84M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for InxMed runs through 2022; nothing later has been disclosed. Investors on record include China Growth Capital, SDIC, CD Capital. 3 distinct backers are named across the disclosed rounds.

InxMed at a glance

Total raised: $84M
Latest round: Series B
Latest round date: March 2022
Headquarters: Nanjing, China
Notable investors: China Growth Capital, SDIC, CD Capital

Frequently asked about InxMed funding

How much has InxMed raised?: InxMed has raised $84M in total disclosed funding across the rounds on record.
Who has invested in InxMed?: China Growth Capital, SDIC, CD Capital are named among the investors backing InxMed.
What was the latest InxMed funding round?: The most recent disclosed round is a Series B, announced in March 2022.
Where is InxMed based?: InxMed is based in Nanjing, China.
When did InxMed last raise?: The last disclosed InxMed round closed in March 2022 at Series B.

InxMed totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Nanjing below to benchmark round size and investor mix.

InxMed Funding: $84M Raised, Series B (2022)

InxMed funding overview

InxMed at a glance

Frequently asked about InxMed funding

Companies related to InxMed (26)

Browse related funding lists (5)